Strong False-Positive Pretransplant Flow Cytometric Crossmatch Induced by Non-HLA Autoantibodies in a Nonsensitized Renal Transplant Candidate
Transplantation Proceedings · 2026-06 · 58 (5) · 886-889
DOI: 10.1016/j.transproceed.2026.04.023 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transplantation Proceedings, 2026-06. Verfasst von Bo Young Yoon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Dong-A University Hospital, Busan, Republic of Korea. Hauptthemen laut MEDLINE: Kidney Transplantation, Autoantibodies, Flow Cytometry, Histocompatibility Testing. Die Arbeit nennt 14 Literaturangaben. Gefördert von: Dong-A University.
Abstract (Originalsprache)
Flow cytometric crossmatch (FCXM) is a sensitive method for detecting donor-specific antibodies in kidney transplantation; however, false-positive results may occur in the absence of HLA antibodies. We report a case of a 46-year-old nonsensitized male kidney transplant candidate who demonstrated persistent strong T-cell FCXM positivity despite repeatedly negative HLA antibody screening by single antigen bead assay. Complement-dependent cytotoxicity crossmatch was negative for both T and B lymphocytes. The patient had no history of prior sensitizing events, including transfusion, transplantation, or pregnancy. To exclude assay interference, serum pretreatment with EDTA, serial dilution, heat inactivation, and dithiothreitol was performed, and no clinically relevant HLA donor-specific antibodies were identified. Extended non-HLA antibody screening revealed multiple autoantibodies, including antibodies against viemtin, leucine-rich repeat transmembrane protein 2, tubulin alpha-1B chain, and CD36. These non-HLA autoantibodies were considered the most likely cause of the isolated T-cell FCXM positivity. This case highlights the diagnostic challenge posed by discordant crossmatch results and emphasizes the importance of considering non-HLA antibodies in the interpretation of FCXM. Identification of non-HLA antibody-mediated FCXM positivity may help avoid unnecessary exclusion of transplant candidates and support more informed immunologic risk assessment in pretransplant evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Dong-A University Hospital, Busan, Republic of Korea.
- Department of Surgery, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Republic of Korea.
- Department of Laboratory Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Republic of Korea. Electronic address: ihjeong@dau.ac.kr.
Förderung
- Dong-A University
Zitieren
APA
Yoon, B. Y., Kang, A. J., Chung, Y. S., & Jeong, I. H. (2026). Strong False-Positive Pretransplant Flow Cytometric Crossmatch Induced by Non-HLA Autoantibodies in a Nonsensitized Renal Transplant Candidate. Transplantation Proceedings, 58(5), 886-889. https://doi.org/10.1016/j.transproceed.2026.04.023
Vancouver
Yoon BY, Kang AJ, Chung YS, Jeong IH. Strong False-Positive Pretransplant Flow Cytometric Crossmatch Induced by Non-HLA Autoantibodies in a Nonsensitized Renal Transplant Candidate. Transplantation Proceedings. 2026;58(5):886-889. doi:10.1016/j.transproceed.2026.04.023
BibTeX
@article{Yoon2026,
author = {Yoon, Bo Young and Kang, Ae Jung and Chung, Young Soo and Jeong, In Hwa},
title = {Strong False-Positive Pretransplant Flow Cytometric Crossmatch Induced by Non-HLA Autoantibodies in a Nonsensitized Renal Transplant Candidate},
journal = {Transplantation Proceedings},
year = {2026},
volume = {58},
number = {5},
pages = {886--889},
doi = {10.1016/j.transproceed.2026.04.023}
}
EUVIMED